Claim: In her career as a researcher, Sharon Anderson has expanded understanding of the pathophysiology of diabetic nephropathy (one of the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally), and has uncovered the important effect of ACE inhibitors in modifying the progression of diabetic nephropathy.
Evidence: In her career as a researcher, she has expanded understanding of the pathophysiology of diabetic nephropathy, which has, in turn, changed the practice patterns for treatment of the disease. Diabetic nephropathy is one of the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally. Her work uncovered the important effect of ACE inhibitors in modifying the progression of diabetic nephropathy.